Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is the timeframe for the FDA’s review of VX-770?

April 26, 2017fda review timeframe vx-770

0

Posted

What is the timeframe for the FDA’s review of VX-770?

1 Answer

0

Posted

Results from the Phase 3 registration program are expected in the first half of 2011, and Vertex expects it will submit a New Drug Application for VX-770 to the U.S. Food and Drug Administration in the second half of 2011.